Status:
COMPLETED
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study examines the impact of Cognitive-Behavior Therapy (CBT) on symptoms, physiological arousal, stressors, and the ways to deal with them in individuals with schizophrenia and related disorders...
Detailed Description
This study examines the mechanisms of recovery from psychosis. Specifically, the study aims to evaluate the putative impact of enhancing cognitive coping strategies via Cognitive-Behavior Therapy for ...
Eligibility Criteria
Inclusion
- Males and females between ages 18-50.
- Have capacity to give informed consent.
- English speaking.
- Have a DSM-IV diagnosis of schizophrenia, or schizoaffective disorder, or schizophreniform disorder.
- Presence of active psychosis as indexed by ratings ≥3 on any hallucinations and delusions items of the Scale for Assessment of Positive Symptoms (SAPS).
Exclusion
- Lacks capacity to give informed consent.
- Diagnosis of mental retardation (IQ \< 80).
- Have history of neurological disorders or medical conditions known to seriously affect the brain.
- Have history of cardiac conditions or hypertension; current use of anti-cholinergic, beta-blockers, anti-histamine, or anti-hypertensive medication; abnormalities on ECG.
- Have used street drugs within the past 4 weeks.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00791440
Start Date
November 1 2008
End Date
June 1 2012
Last Update
December 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University & New York State Psyciatric Institute
New York, New York, United States, 10032